Zerbaxa
Looking at 2 Antimicrobials for Drug-Resistant Pseudomonas aeruginosa
The purpose of this review is to discuss the in vitro activity and real-world evidence of ceftolozane-tazobactam ...
FEBRUARY 26, 2025
New Guidance for AMR Gram-Negative Infections
The Infectious Diseases Society of America recently updated guidance for the treatment of antimicrobial-resistant ...
AUGUST 23, 2024
FDA Grants HABP/VABP Indication for Zerbaxa
The FDA approved a new indication for ceftolozane-tazobactam to treat hospital-acquired bacterial pneumonia and ...
JUNE 3, 2019
FDA Accepts Antibiotics NDA and sNDA for Priority Review
The FDA granted priority reviews for two of Merck's antibiotics.
FEBRUARY 5, 2019
Merck to Seek New Indication for Zerbaxa
Zerbaxa is being studied for hospital-acquired bacterial pneumonia or ventilator-associated bacterial pneumonia ...
SEPTEMBER 18, 2018
The ‘Perfect Storm’ That Hampers Stewardship
Antimicrobial resistance continues to present a challenge to patient care for gram-negative bacterial infections, ...
NOVEMBER 14, 2017
